Precision Biosciences (DTIL) Return on Capital Employed Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 970.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 970.00 |
| Dec 31, 2025 | -2,518.00 |
| Sep 30, 2025 | -9,282.00 |
| Jun 30, 2025 | -8,227.00 |
| Mar 31, 2025 | -1,248.00 |
| Dec 31, 2024 | 1,887.00 |
| Sep 30, 2024 | 2,248.00 |
| Jun 30, 2024 | 2,653.00 |
| Mar 31, 2024 | 1,506.00 |
| Dec 31, 2023 | 382.00 |
| Sep 30, 2023 | 1,235.00 |
| Jun 30, 2023 | 2,185.00 |
| Mar 31, 2023 | -1,127.00 |
| Dec 31, 2022 | -2,137.00 |
| Sep 30, 2022 | -2,909.00 |
| Jun 30, 2022 | -3,129.00 |
| Mar 31, 2022 | 4,229.00 |
| Dec 31, 2021 | 7,272.00 |
| Sep 30, 2021 | 6,376.00 |
| Jun 30, 2021 | 4,095.00 |
| Mar 31, 2021 | -2,358.00 |
| Dec 31, 2020 | -5,471.00 |
| Sep 30, 2020 | -4,688.00 |
| Jun 30, 2020 | -2,881.00 |
| Mar 31, 2020 | 2,416.00 |